{"product_id":"primaa","title":"Primaa","description":"\u003cstyle\u003e\n.guidaio-v3 { --gv3-bg:#f6f5fb;--gv3-surface:#fff;--gv3-surface-soft:#fbfaff;--gv3-ink:#14132b;--gv3-ink-2:#2b2a4a;--gv3-muted:#6c6a8a;--gv3-line:#ecebf5;--gv3-line-2:#e0deef;--gv3-brand:#5b3df5;--gv3-brand-2:#7c63ff;--gv3-brand-soft:#efeaff;--gv3-brand-ink:#2c1d8a;--gv3-ok:#0f8a5a;--gv3-ok-soft:#e6f7ee;--gv3-warn:#b16800;--gv3-warn-soft:#fff3dc;--gv3-bad:#b3261e;--gv3-bad-soft:#fde7e6;--gv3-radius-lg:22px;--gv3-radius:16px;--gv3-radius-sm:10px;--gv3-shadow-sm:0 1px 2px rgba(20,19,43,.04);--gv3-shadow:0 12px 30px rgba(53,38,124,.07);\n  background:radial-gradient(1200px 600px at 80% -10%,rgba(124,99,255,.18),transparent 60%),radial-gradient(900px 500px at -10% 5%,rgba(91,61,245,.12),transparent 60%),var(--gv3-bg);\n  color:var(--gv3-ink);font-family:Inter,system-ui,-apple-system,\"Segoe UI\",Roboto,sans-serif;font-size:16px;line-height:1.6;-webkit-font-smoothing:antialiased;\n  max-width:1240px;margin:0 auto;padding:24px 16px 64px;border-radius:var(--gv3-radius-lg);}\n.guidaio-v3 *,.guidaio-v3 *::before,.guidaio-v3 *::after{box-sizing:border-box}\n.guidaio-v3 a{color:var(--gv3-brand);text-decoration:none}.guidaio-v3 a:hover{text-decoration:underline}\n.guidaio-v3 img{max-width:100%;display:block}\n.guidaio-v3 h1,.guidaio-v3 h2,.guidaio-v3 h3,.guidaio-v3 h4{font-family:\"Space Grotesk\",Inter,sans-serif;letter-spacing:-.01em;margin:0;color:var(--gv3-ink)}\n.guidaio-v3 svg{display:inline-block;vertical-align:middle}\n.guidaio-v3 .hero{position:relative;background:radial-gradient(700px 320px at 90% 0%,rgba(124,99,255,.18),transparent 70%),linear-gradient(180deg,#fff 0%,#fbfaff 100%);border:1px solid var(--gv3-line);border-radius:var(--gv3-radius-lg);box-shadow:var(--gv3-shadow);padding:32px;overflow:hidden}\n.guidaio-v3 .hero-grid{display:grid;grid-template-columns:minmax(0,1.5fr) minmax(280px,1fr);gap:28px;align-items:start}\n.guidaio-v3 .hero-head{display:flex;gap:16px;align-items:flex-start}\n.guidaio-v3 .logo-tile{width:72px;height:72px;border-radius:18px;border:1px solid var(--gv3-line-2);background:#fff;box-shadow:var(--gv3-shadow-sm);display:grid;place-items:center;overflow:hidden;flex:0 0 auto}\n.guidaio-v3 .logo-tile img{width:56px;height:56px;object-fit:contain}\n.guidaio-v3 .eyebrow{display:inline-flex;align-items:center;gap:6px;color:var(--gv3-brand-ink);background:var(--gv3-brand-soft);padding:6px 12px;border-radius:999px;font-size:12px;font-weight:700;letter-spacing:.04em;text-transform:uppercase}\n.guidaio-v3 h1.title{margin-top:12px;font-size:34px;line-height:1.1;color:var(--gv3-ink)}\n.guidaio-v3 .lede{margin:14px 0 0;font-size:17px;color:var(--gv3-ink-2);max-width:60ch}\n.guidaio-v3 .badge-row,.guidaio-v3 .chip-row{display:flex;flex-wrap:wrap;gap:8px;margin-top:16px}\n.guidaio-v3 .badge{display:inline-flex;align-items:center;gap:6px;padding:6px 11px;border-radius:999px;font-size:12px;font-weight:600;background:#fff;border:1px solid var(--gv3-line-2);color:var(--gv3-ink-2)}\n.guidaio-v3 .badge.ok{background:var(--gv3-ok-soft);color:var(--gv3-ok);border-color:#b8e8cc}\n.guidaio-v3 .badge.warn{background:var(--gv3-warn-soft);color:var(--gv3-warn);border-color:#f1d6a3}\n.guidaio-v3 .badge.bad{background:var(--gv3-bad-soft);color:var(--gv3-bad);border-color:#f5c2c0}\n.guidaio-v3 .badge.brand{background:var(--gv3-brand-soft);color:var(--gv3-brand-ink);border-color:#d6cdfb}\n.guidaio-v3 .tbd-row{margin-top:14px;display:grid;gap:10px}\n.guidaio-v3 .tbd-row .label{font-size:11px;font-weight:700;letter-spacing:.06em;text-transform:uppercase;color:var(--gv3-muted)}\n.guidaio-v3 .chip{display:inline-flex;align-items:center;gap:6px;padding:5px 11px;border-radius:999px;font-size:13px;border:1px solid var(--gv3-line-2);background:#fff;color:var(--gv3-ink-2)}\n.guidaio-v3 .chip.cat{background:#eef2ff;color:#3730a3;border-color:#c7d2fe}\n.guidaio-v3 .chip.dom{background:#ecfeff;color:#0e7490;border-color:#a5f3fc}\n.guidaio-v3 .chip.prof{background:#fdf4ff;color:#86198f;border-color:#f5d0fe}\n.guidaio-v3 .cta-row{display:flex;gap:10px;flex-wrap:wrap;margin-top:22px}\n.guidaio-v3 .btn{display:inline-flex;align-items:center;gap:8px;padding:11px 16px;border-radius:12px;font-weight:700;border:1px solid transparent;cursor:pointer;font-size:14px}\n.guidaio-v3 .btn:hover{text-decoration:none}\n.guidaio-v3 .btn-primary{background:linear-gradient(135deg,var(--gv3-brand) 0%,var(--gv3-brand-2) 100%);color:#fff;box-shadow:0 14px 28px rgba(91,61,245,.28)}\n.guidaio-v3 .btn-secondary{background:#fff;color:var(--gv3-brand-ink);border-color:#d6cdfb}\n.guidaio-v3 .btn-ghost{background:transparent;color:var(--gv3-ink-2);border-color:var(--gv3-line-2)}\n.guidaio-v3 .affiliate-note{margin-top:10px;font-size:12px;color:var(--gv3-muted)}\n.guidaio-v3 .snapshot{background:#fff;border:1px solid var(--gv3-line);border-radius:var(--gv3-radius-lg);padding:20px;box-shadow:var(--gv3-shadow)}\n.guidaio-v3 .snapshot h3{font-size:13px;text-transform:uppercase;letter-spacing:.08em;color:var(--gv3-brand-ink);margin-bottom:14px}\n.guidaio-v3 .snapshot dl{margin:0;display:grid;grid-template-columns:1fr;gap:12px}\n.guidaio-v3 .snapshot .row{display:grid;grid-template-columns:1fr auto;gap:8px;padding-bottom:12px;border-bottom:1px dashed var(--gv3-line-2)}\n.guidaio-v3 .snapshot .row:last-child{border-bottom:0;padding-bottom:0}\n.guidaio-v3 .snapshot dt{color:var(--gv3-muted);font-size:13px;margin:0}\n.guidaio-v3 .snapshot dd{margin:0;text-align:right;font-weight:700;color:var(--gv3-ink);font-size:13px}\n.guidaio-v3 .snapshot dd small{display:block;font-weight:500;color:var(--gv3-muted);font-size:11px;text-align:right}\n.guidaio-v3 .price-big{font-family:\"Space Grotesk\";font-size:20px;line-height:1}\n.guidaio-v3 .toc{margin:20px 0 24px;padding:10px;background:rgba(255,255,255,.85);border:1px solid var(--gv3-line);border-radius:22px;box-shadow:var(--gv3-shadow-sm);display:flex;flex-wrap:wrap;gap:8px;overflow-x:auto}\n.guidaio-v3 .toc a{padding:8px 14px;border-radius:999px;font-size:13px;font-weight:600;color:var(--gv3-brand-ink);background:#fff;white-space:nowrap;border:1px solid var(--gv3-line-2);box-shadow:var(--gv3-shadow-sm);transition:transform .18s ease,box-shadow .18s ease,background .18s ease,color .18s ease,border-color .18s ease}\n.guidaio-v3 .toc a:hover{background:linear-gradient(135deg,var(--gv3-brand) 0%,var(--gv3-brand-2) 100%);color:#fff;border-color:transparent;transform:translateY(-2px) scale(1.04);box-shadow:0 8px 18px rgba(91,61,245,.25);text-decoration:none}\n.guidaio-v3 .justify{text-align:justify;text-justify:inter-word;hyphens:auto}\n.guidaio-v3 a.chip,.guidaio-v3 a.chip:hover{text-decoration:none}\n.guidaio-v3 a.chip{transition:transform .15s ease,box-shadow .15s ease,filter .15s ease;cursor:pointer}\n.guidaio-v3 a.chip:hover{transform:translateY(-1px);box-shadow:0 4px 10px rgba(53,38,124,.12);filter:brightness(.96)}\n.guidaio-v3 section.block{background:var(--gv3-surface);border:1px solid var(--gv3-line);border-radius:var(--gv3-radius-lg);padding:32px;margin-top:22px;box-shadow:var(--gv3-shadow-sm);scroll-margin-top:90px}\n.guidaio-v3 section.block.soft{background:var(--gv3-surface-soft)}\n.guidaio-v3 section.block .head{margin-bottom:20px}\n.guidaio-v3 section.block .eyebrow + h2{margin-top:10px}\n.guidaio-v3 section.block h2{font-size:24px;color:var(--gv3-ink)}\n.guidaio-v3 section.block .lead{margin-top:8px;color:var(--gv3-muted);max-width:70ch}\n.guidaio-v3 .grid-2{display:grid;grid-template-columns:repeat(2,minmax(0,1fr));gap:16px}\n.guidaio-v3 .grid-3{display:grid;grid-template-columns:repeat(3,minmax(0,1fr));gap:14px}\n.guidaio-v3 .rich p{margin:0 0 14px}.guidaio-v3 .rich p:last-child{margin:0}\n.guidaio-v3 ul.brand-list{list-style:none;padding:0;margin:0;display:grid;gap:10px}\n.guidaio-v3 ul.brand-list li{position:relative;padding-left:26px;color:var(--gv3-ink-2)}\n.guidaio-v3 ul.brand-list li::before{content:\"\";position:absolute;left:0;top:9px;width:14px;height:14px;border-radius:999px;background:var(--gv3-brand-soft);box-shadow:inset 0 0 0 4px var(--gv3-brand)}\n.guidaio-v3 ol.steps{list-style:none;counter-reset:s;padding:0;margin:0;display:grid;gap:14px}\n.guidaio-v3 ol.steps li{counter-increment:s;position:relative;padding-left:42px;color:var(--gv3-ink-2);min-height:30px}\n.guidaio-v3 ol.steps li::before{content:counter(s);position:absolute;left:0;top:0;width:30px;height:30px;border-radius:999px;background:linear-gradient(135deg,var(--gv3-brand) 0%,var(--gv3-brand-2) 100%);color:#fff;display:grid;place-items:center;font-weight:700;font-size:13px;box-shadow:0 6px 14px rgba(91,61,245,.25)}\n.guidaio-v3 .feature-card{border:1px solid var(--gv3-line);border-radius:var(--gv3-radius);padding:16px;background:#fff;display:grid;gap:8px}\n.guidaio-v3 .feature-card .icbox{width:36px;height:36px;border-radius:12px;background:var(--gv3-brand-soft);color:var(--gv3-brand-ink);display:grid;place-items:center}\n.guidaio-v3 .feature-card .ftitle{font-weight:700;color:var(--gv3-ink);font-size:15px}\n.guidaio-v3 .feature-card .fbody{color:var(--gv3-muted);font-size:13px}\n.guidaio-v3 .pc{border-radius:var(--gv3-radius);padding:20px;border:1px solid var(--gv3-line)}\n.guidaio-v3 .pc.pros{background:var(--gv3-ok-soft);border-color:#b8e8cc}\n.guidaio-v3 .pc.cons{background:var(--gv3-bad-soft);border-color:#f5c2c0}\n.guidaio-v3 .pc h3{font-size:17px;display:flex;align-items:center;gap:8px;margin-bottom:12px}\n.guidaio-v3 .pc.pros h3{color:var(--gv3-ok)}.guidaio-v3 .pc.cons h3{color:var(--gv3-bad)}\n.guidaio-v3 .pc ul{list-style:none;padding:0;margin:0;display:grid;gap:8px}\n.guidaio-v3 .pc li{display:flex;gap:8px;align-items:flex-start;color:var(--gv3-ink-2);font-size:14px}\n.guidaio-v3 .pc li svg{flex:0 0 auto;margin-top:3px}\n.guidaio-v3 .pc.pros li svg{color:var(--gv3-ok)}.guidaio-v3 .pc.cons li svg{color:var(--gv3-bad)}\n.guidaio-v3 .bestnot{display:grid;grid-template-columns:1fr 1fr;gap:16px}\n.guidaio-v3 .bestnot .card{border:1px solid var(--gv3-line);border-radius:var(--gv3-radius);padding:20px;background:#fff}\n.guidaio-v3 .bestnot h3{display:flex;align-items:center;gap:8px;font-size:17px;margin-bottom:12px}\n.guidaio-v3 .bestnot .for h3{color:var(--gv3-ok)}.guidaio-v3 .bestnot .not h3{color:var(--gv3-warn)}\n.guidaio-v3 .plan-grid{display:grid;grid-template-columns:repeat(3,minmax(0,1fr));gap:14px}\n.guidaio-v3 .plan{border:1px solid var(--gv3-line);border-radius:var(--gv3-radius-lg);padding:22px;background:#fff;display:grid;gap:10px;position:relative}\n.guidaio-v3 .plan.featured{border-color:#c7baff;background:linear-gradient(180deg,#fff 0%,#f7f3ff 100%);box-shadow:var(--gv3-shadow)}\n.guidaio-v3 .plan .pill{position:absolute;top:-12px;right:14px;background:linear-gradient(135deg,var(--gv3-brand) 0%,var(--gv3-brand-2) 100%);color:#fff;font-size:11px;font-weight:700;letter-spacing:.06em;padding:5px 9px;border-radius:999px;text-transform:uppercase}\n.guidaio-v3 .plan .pname{font-family:\"Space Grotesk\";font-weight:700;font-size:17px}\n.guidaio-v3 .plan .pprice{font-family:\"Space Grotesk\";font-size:24px;font-weight:700}\n.guidaio-v3 .plan .pprice small{font-size:13px;font-weight:500;color:var(--gv3-muted)}\n.guidaio-v3 .plan ul{list-style:none;padding:0;margin:6px 0 0;display:grid;gap:8px}\n.guidaio-v3 .plan ul li{display:flex;gap:8px;align-items:flex-start;color:var(--gv3-ink-2);font-size:14px}\n.guidaio-v3 .plan ul li svg{color:var(--gv3-brand);flex:0 0 auto;margin-top:3px}\n.guidaio-v3 .pricing-extras{margin-top:16px;display:grid;gap:10px}\n.guidaio-v3 .offer{display:flex;gap:10px;align-items:flex-start;padding:12px 14px;border-radius:12px;background:#fff7e6;border:1px solid #f1d6a3;color:var(--gv3-warn);font-size:14px}\n.guidaio-v3 .offer svg{flex:0 0 auto;margin-top:2px}\n.guidaio-v3 .trust-grid{display:grid;grid-template-columns:2fr 1fr;gap:16px}\n.guidaio-v3 .trust-grid .col{display:grid;gap:14px}\n.guidaio-v3 .trust-card{background:#fff;border:1px solid var(--gv3-line);border-radius:var(--gv3-radius);padding:20px}\n.guidaio-v3 .trust-card h3{font-size:15px;margin-bottom:10px}\n.guidaio-v3 .kv{display:grid;grid-template-columns:180px 1fr;gap:12px;padding:10px 0;border-top:1px solid var(--gv3-line)}\n.guidaio-v3 .kv:first-child{border-top:0;padding-top:0}\n.guidaio-v3 .kv .k{color:var(--gv3-muted);font-size:13px}\n.guidaio-v3 .kv .v{color:var(--gv3-ink);font-size:14px}\n.guidaio-v3 .availability{display:grid;grid-template-columns:1fr 1fr;gap:16px}\n.guidaio-v3 .availability .card{border:1px solid var(--gv3-line);border-radius:var(--gv3-radius);background:#fff;padding:18px}\n.guidaio-v3 .flag-row{display:flex;flex-wrap:wrap;gap:8px}\n.guidaio-v3 .flag{display:inline-flex;align-items:center;gap:5px;padding:5px 10px;border-radius:999px;background:#fff;border:1px solid var(--gv3-line-2);font-size:13px;color:var(--gv3-ink-2)}\n.guidaio-v3 section.block.watch{background:#fffaf0;border:1px solid #f1d6a3}\n.guidaio-v3 section.block.watch .head h2{color:var(--gv3-warn)}\n.guidaio-v3 .setup-grid{display:grid;grid-template-columns:1fr 1fr;gap:16px}\n.guidaio-v3 .setup-card{background:#fff;border:1px solid var(--gv3-line);border-radius:var(--gv3-radius);padding:20px}\n.guidaio-v3 .integrations{display:flex;flex-wrap:wrap;gap:8px}\n.guidaio-v3 .integration{display:inline-flex;align-items:center;gap:6px;padding:7px 11px;border-radius:12px;background:#fff;border:1px solid var(--gv3-line-2);color:var(--gv3-ink-2);font-size:13px;font-weight:600}\n.guidaio-v3 .company-grid{display:grid;grid-template-columns:1.4fr 1fr;gap:16px}\n.guidaio-v3 .company-card{border:1px solid var(--gv3-line);border-radius:var(--gv3-radius);background:#fff;padding:20px}\n.guidaio-v3 .timeline{display:grid;gap:8px;margin:8px 0 0}\n.guidaio-v3 .timeline .ev{padding:10px 14px;border-radius:12px;background:var(--gv3-brand-soft);color:var(--gv3-brand-ink);font-weight:600;font-size:14px;display:flex;align-items:center;gap:8px}\n.guidaio-v3 .social-row{display:flex;gap:8px;flex-wrap:wrap}\n.guidaio-v3 .social{width:36px;height:36px;border-radius:12px;border:1px solid var(--gv3-line-2);background:#fff;display:grid;place-items:center;color:var(--gv3-ink-2)}\n.guidaio-v3 .social:hover{background:var(--gv3-brand-soft);color:var(--gv3-brand-ink);border-color:#d6cdfb}\n.guidaio-v3 .res-grid{display:grid;grid-template-columns:repeat(3,minmax(0,1fr));gap:10px}\n.guidaio-v3 .res{display:flex;gap:10px;align-items:center;padding:10px 12px;border-radius:12px;border:1px solid var(--gv3-line);background:#fff;color:var(--gv3-ink-2);font-size:13px}\n.guidaio-v3 .res:hover{border-color:#d6cdfb;background:#fbfaff;text-decoration:none}\n.guidaio-v3 .res svg{color:var(--gv3-brand);flex:0 0 auto}\n.guidaio-v3 .res .url{color:var(--gv3-muted);font-size:11px;word-break:break-all}\n.guidaio-v3 .res .res-text{display:grid}\n.guidaio-v3 .alts{display:flex;flex-wrap:wrap;gap:8px}\n.guidaio-v3 .alt{display:inline-flex;align-items:center;gap:8px;padding:9px 13px;border-radius:14px;background:#fff;border:1px solid var(--gv3-line-2);font-weight:600;color:var(--gv3-ink-2);font-size:14px}\n.guidaio-v3 .alt .av{width:24px;height:24px;border-radius:8px;background:linear-gradient(135deg,#c7baff 0%,#efeaff 100%);display:grid;place-items:center;font-size:12px;font-weight:700;color:var(--gv3-brand-ink)}\n.guidaio-v3 .faq{display:grid;gap:10px}\n.guidaio-v3 .faq details{background:#fff;border:1px solid var(--gv3-line);border-radius:var(--gv3-radius);padding:14px 16px}\n.guidaio-v3 .faq summary{cursor:pointer;list-style:none;font-weight:700;color:var(--gv3-ink);display:flex;justify-content:space-between;align-items:center;gap:10px;font-size:15px}\n.guidaio-v3 .faq summary::-webkit-details-marker{display:none}\n.guidaio-v3 .faq summary svg{color:var(--gv3-brand)}\n.guidaio-v3 .faq .ans{color:var(--gv3-muted);margin-top:10px;font-size:14px}\n.guidaio-v3 section.block.conclusion{background:radial-gradient(700px 320px at 0% 0%,rgba(124,99,255,.18),transparent 60%),linear-gradient(135deg,#1c163a 0%,#2c1d8a 100%);color:#fff;border-color:#2c1d8a}\n.guidaio-v3 section.block.conclusion .head h2{color:#fff}\n.guidaio-v3 section.block.conclusion .lead,.guidaio-v3 section.block.conclusion .rich p{color:rgba(255,255,255,.88)}\n.guidaio-v3 section.block.conclusion .rich strong,.guidaio-v3 section.block.conclusion .rich b{color:#fff}\n.guidaio-v3 section.block.conclusion .eyebrow{background:rgba(255,255,255,.14);color:#fff}\n.guidaio-v3 section.block.conclusion .btn-secondary{background:rgba(255,255,255,.14);color:#fff;border-color:rgba(255,255,255,.25)}\n@media (max-width:1080px){.guidaio-v3 .hero-grid,.guidaio-v3 .trust-grid,.guidaio-v3 .company-grid,.guidaio-v3 .setup-grid,.guidaio-v3 .availability{grid-template-columns:1fr}.guidaio-v3 .grid-3,.guidaio-v3 .res-grid,.guidaio-v3 .plan-grid{grid-template-columns:repeat(2,minmax(0,1fr))}}\n@media (max-width:700px){.guidaio-v3{padding:12px 8px 48px}.guidaio-v3 .hero{padding:20px}.guidaio-v3 section.block{padding:20px}.guidaio-v3 .grid-2,.guidaio-v3 .grid-3,.guidaio-v3 .res-grid,.guidaio-v3 .plan-grid,.guidaio-v3 .bestnot,.guidaio-v3 .availability{grid-template-columns:1fr}.guidaio-v3 h1.title{font-size:28px}}\n\u003c\/style\u003e\n\u003cdiv class=\"guidaio-v3\" itemscope itemtype=\"https:\/\/schema.org\/SoftwareApplication\"\u003e\n\u003cmeta itemprop=\"name\" content=\"Primaa: CE-IVDR AI for Cancer Diagnosis in Pathology\"\u003e\n\u003cmeta itemprop=\"description\" content=\"Primaa's Cleo Breast and Cleo Skin bring CE-IVDR marked AI to digital pathology, detecting breast and skin cancer biomarkers on whole-slide images.\"\u003e\n\u003cdiv class=\"hero\"\u003e\u003cdiv class=\"hero-grid\"\u003e\n\u003cdiv\u003e\n\u003cdiv class=\"hero-head\"\u003e\n\u003cdiv class=\"logo-tile\"\u003e\u003cimg src=\"https:\/\/primaalab.com\/wp-content\/uploads\/2023\/12\/cropped-favicon-primaa-192x192.png\" alt=\"Primaa logo\" itemprop=\"image\" loading=\"lazy\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"name-block\"\u003e\n\u003cspan class=\"eyebrow\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpath d=\"m12 3-1.9 5.8a2 2 0 0 1-1.3 1.3L3 12l5.8 1.9a2 2 0 0 1 1.3 1.3L12 21l1.9-5.8a2 2 0 0 1 1.3-1.3L21 12l-5.8-1.9a2 2 0 0 1-1.3-1.3Z\"\u003e\u003c\/path\u003e\u003c\/svg\u003e Healthcare Medical Scribes · Workflow Automation\u003c\/span\u003e\u003ch1 class=\"title\" itemprop=\"name\"\u003ePrimaa\u003c\/h1\u003e\n\u003cp class=\"lede justify\" itemprop=\"description\"\u003ePrimaa is a French MedTech platform that applies deep learning to digitised histology slides, helping pathologists detect and quantify breast and skin cancer biomarkers. Its CE-IVDR marked Cleo Breast and Cleo Skin solutions prioritise cases and speed up reporting.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"badge-row\"\u003e\n\u003cspan class=\"badge ok\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003ccircle cx=\"12\" cy=\"12\" r=\"10\"\u003e\u003c\/circle\u003e\u003cpath d=\"m9 12 2 2 4-4\"\u003e\u003c\/path\u003e\u003c\/svg\u003e Active\u003c\/span\u003e\u003cspan class=\"badge ok\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpath d=\"M12 22s8-4 8-10V5l-8-3-8 3v7c0 6 8 10 8 10z\"\u003e\u003c\/path\u003e\u003cpath d=\"m9 12 2 2 4-4\"\u003e\u003c\/path\u003e\u003c\/svg\u003e GDPR compliant\u003c\/span\u003e\u003cspan class=\"badge\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpolyline points=\"22 7 13.5 15.5 8.5 10.5 2 17\"\u003e\u003c\/polyline\u003e\u003cpolyline points=\"16 7 22 7 22 13\"\u003e\u003c\/polyline\u003e\u003c\/svg\u003e Contact Sales\u003c\/span\u003e\u003cspan class=\"badge\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpath d=\"M6.3 20.3a2.4 2.4 0 0 0 3.4 0L12 18l-6-6-2.3 2.3a2.4 2.4 0 0 0 0 3.4Z\"\u003e\u003c\/path\u003e\u003cpath d=\"m2 22 3-3\"\u003e\u003c\/path\u003e\u003cpath d=\"M7.5 13.5 10 11\"\u003e\u003c\/path\u003e\u003cpath d=\"M10.5 16.5 13 14\"\u003e\u003c\/path\u003e\u003cpath d=\"m18 3-4 4h6l-4 4\"\u003e\u003c\/path\u003e\u003c\/svg\u003e No public API\u003c\/span\u003e\u003cspan class=\"badge brand\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003ccircle cx=\"12\" cy=\"12\" r=\"10\"\u003e\u003c\/circle\u003e\u003cpath d=\"m9 12 2 2 4-4\"\u003e\u003c\/path\u003e\u003c\/svg\u003e Verified by Guidaio\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"tbd-row\"\u003e\n\u003cdiv\u003e\n\u003cdiv class=\"label\"\u003eCategories\u003c\/div\u003e\n\u003cdiv class=\"chip-row\"\u003e\n\u003ca class=\"chip cat\" href=\"\/collections\/healthcare-medical-scribes\"\u003eHealthcare Medical Scribes\u003c\/a\u003e\u003ca class=\"chip cat\" href=\"\/collections\/workflow-automation\"\u003eWorkflow Automation\u003c\/a\u003e\u003ca class=\"chip cat\" href=\"\/collections\/academic-research\"\u003eAcademic Research\u003c\/a\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdiv class=\"label\"\u003eTarget domains\u003c\/div\u003e\n\u003cdiv class=\"chip-row\"\u003e\n\u003ca class=\"chip dom\" href=\"\/collections\/healthcare-medicine\"\u003eHealthcare Medicine\u003c\/a\u003e\u003ca class=\"chip dom\" href=\"\/collections\/biotech-pharma\"\u003eBiotech Pharma\u003c\/a\u003e\u003ca class=\"chip dom\" href=\"\/collections\/science-r-d\"\u003eScience R D\u003c\/a\u003e\u003ca class=\"chip dom\" href=\"\/collections\/data-ai\"\u003eData Ai\u003c\/a\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"cta-row\"\u003e\u003ca class=\"btn btn-primary\" href=\"https:\/\/primaalab.com\/\" target=\"_blank\" rel=\"noopener\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"16\" height=\"16\"\u003e\u003cpath d=\"M15 3h6v6\"\u003e\u003c\/path\u003e\u003cpath d=\"M10 14 21 3\"\u003e\u003c\/path\u003e\u003cpath d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\u003e\u003c\/path\u003e\u003c\/svg\u003e Discover Primaa\u003c\/a\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003caside class=\"snapshot\"\u003e\u003ch3\u003eSnapshot\u003c\/h3\u003e\n\u003cdl\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdt\u003ePricing model\u003c\/dt\u003e\n\u003cdd\u003eContact Sales\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdt\u003eAPI available\u003c\/dt\u003e\n\u003cdd\u003eNo\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdt\u003eTool status\u003c\/dt\u003e\n\u003cdd\u003eActive\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdt\u003eCountry of origin\u003c\/dt\u003e\n\u003cdd\u003e🇫🇷 France\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003c\/dl\u003e\u003c\/aside\u003e\n\u003c\/div\u003e\u003c\/div\u003e\n\u003cnav class=\"toc\" aria-label=\"Page sections\"\u003e\u003ca href=\"#what\"\u003eWhat is it\u003c\/a\u003e\u003ca href=\"#bestnot\"\u003eWhen to use Primaa \/ When not to\u003c\/a\u003e\u003ca href=\"#how\"\u003eHow to use\u003c\/a\u003e\u003ca href=\"#proscons\"\u003ePros \u0026amp; Cons\u003c\/a\u003e\u003ca href=\"#pricing\"\u003ePricing\u003c\/a\u003e\u003ca href=\"#trust\"\u003eTrust \u0026amp; Privacy\u003c\/a\u003e\u003ca href=\"#watch\"\u003eWatch-outs\u003c\/a\u003e\u003ca href=\"#setup\"\u003eSetup \u0026amp; Integrations\u003c\/a\u003e\u003ca href=\"#company\"\u003eCompany\u003c\/a\u003e\u003ca href=\"#resources\"\u003eResources\u003c\/a\u003e\u003ca href=\"#faq\"\u003eFAQ\u003c\/a\u003e\u003ca href=\"#conclusion\"\u003eConclusion\u003c\/a\u003e\u003c\/nav\u003e\n\u003csection class=\"block\" id=\"what\"\u003e\u003cdiv class=\"head\"\u003e\n\u003cspan class=\"eyebrow\"\u003eOverview\u003c\/span\u003e\u003ch2\u003eWhat is Primaa?\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"grid-2\"\u003e\n\u003cdiv class=\"rich justify\"\u003e\n\u003cp\u003e\u003cb\u003ePrimaa\u003c\/b\u003e is a French MedTech company, founded in 2018 and based in Orsay, that develops an AI platform for automated cancer diagnosis in histopathology. Its technology combines image analysis and deep learning applied to \u003ci\u003ewhole-slide images\u003c\/i\u003e — digitised histological tissue slides — and is sold under the \u003cb\u003eCleo\u003c\/b\u003e product range, which currently comprises two organ-specific solutions, both carrying \u003cb\u003eCE-IVDR\u003c\/b\u003e marking.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eCleo Breast\u003c\/b\u003e is an all-in-one primary diagnostic aid for breast tissue. It detects invasive and in situ carcinoma and displays the regions as a heatmap, identifies mitoses and mitotic hotspots with automatic counting, flags potential calcifications, and detects metastases on lymph node slides. A regulatory nuance matters here: macrometastases are CE marked, while micrometastases explicitly are not. Cleo Breast also measures tumour dimensions at any point on the slide.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eCleo Skin\u003c\/b\u003e, presented by the company as the world's first CE-IVDR marked AI solution for dermatopathology, detects and classifies lesions as melanoma, naevus, squamous cell carcinoma or basal cell carcinoma, measures lesion dimensions and margins automatically, and detects mitoses within melanoma regions.\u003c\/p\u003e\n\u003cp\u003eBoth solutions share the same operating model. They act as a \u003ci\u003efirst-read\u003c\/i\u003e tool: the algorithm analyses the slide, prioritises the most critical cases in a smart work list, and the pathologist then reviews the output. Primaa describes the platform as vendor-agnostic and interoperable, integrated into the laboratory workflow and with laboratory machines, and reachable through partner digital pathology platforms including PathPresenter, Proscia, PathAI and Gestalt PathFlow.\u003c\/p\u003e\n\u003cp\u003eThe regulatory framing is explicit and important: Cleo is \u003cb\u003ean aid to diagnosis\u003c\/b\u003e, and its results must be reviewed by accredited doctors. On data, the vendor states that Cleo collects no personal data and that all data stay within the customer's own network. Reported adoption includes more than ten laboratories and clinics in clinical routine and more than forty-five users, with published work covering mitosis detection, multi-centre carcinoma detection and measured reading-time savings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003ch3 style=\"font-size:14px;margin-bottom:12px;color:var(--gv3-brand-ink);text-transform:uppercase;letter-spacing:.08em\"\u003eWhat it does\u003c\/h3\u003e\n\u003cul class=\"brand-list\"\u003e\n\u003cli\u003eDetect invasive and in situ carcinoma on breast whole-slide images\u003c\/li\u003e\n\u003cli\u003eClassify skin lesions as melanoma, naevus, squamous cell or basal cell carcinoma\u003c\/li\u003e\n\u003cli\u003eDetect and automatically count mitoses, including mitotic hotspots\u003c\/li\u003e\n\u003cli\u003ePrioritise the most critical cases through a smart work list\u003c\/li\u003e\n\u003cli\u003eMeasure tumour dimensions and surgical margins automatically\u003c\/li\u003e\n\u003cli\u003eDetect calcifications and lymph node macrometastases\u003c\/li\u003e\n\u003cli\u003eDisplay detected regions as heatmaps for faster visual review\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\n\u003csection class=\"block soft\" id=\"bestnot\"\u003e\u003cdiv class=\"head\"\u003e\n\u003cspan class=\"eyebrow\"\u003eAudience\u003c\/span\u003e\u003ch2\u003eWhen to use Primaa \/ When not to\u003c\/h2\u003e\n\u003cp class=\"lead\"\u003eA quick filter to help you decide if Primaa is the right fit.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"bestnot\"\u003e\n\u003cdiv class=\"card for\"\u003e\n\u003ch3\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"16\" height=\"16\"\u003e\u003cpath d=\"M7 10v12\"\u003e\u003c\/path\u003e\u003cpath d=\"M15 5.88 14 10h5.83a2 2 0 0 1 1.92 2.56l-2.33 8A2 2 0 0 1 17.5 22H4a2 2 0 0 1-2-2v-8a2 2 0 0 1 2-2h2.76a2 2 0 0 0 1.79-1.11L12 2a3.13 3.13 0 0 1 3 3.88Z\"\u003e\u003c\/path\u003e\u003c\/svg\u003e When to use Primaa\u003c\/h3\u003e\n\u003cul class=\"brand-list\"\u003e\n\u003cli\u003ePathology laboratories that have already moved to a fully digital whole-slide imaging workflow\u003c\/li\u003e\n\u003cli\u003ePathologists reporting breast cancer cases in day-to-day clinical routine\u003c\/li\u003e\n\u003cli\u003eDermatopathologists assessing melanoma, basal cell carcinoma and squamous cell carcinoma\u003c\/li\u003e\n\u003cli\u003eLaboratory managers who need intelligent triage and case prioritisation to shorten turnaround times\u003c\/li\u003e\n\u003cli\u003eDigital pathology teams already running PathPresenter, Proscia, PathAI or Gestalt PathFlow\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card not\"\u003e\n\u003ch3\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"16\" height=\"16\"\u003e\u003cpath d=\"M17 14V2\"\u003e\u003c\/path\u003e\u003cpath d=\"M9 18.12 10 14H4.17a2 2 0 0 1-1.92-2.56l2.33-8A2 2 0 0 1 6.5 2H20a2 2 0 0 1 2 2v8a2 2 0 0 1-2 2h-2.76a2 2 0 0 0-1.79 1.11L12 22a3.13 3.13 0 0 1-3-3.88Z\"\u003e\u003c\/path\u003e\u003c\/svg\u003e When not to use Primaa\u003c\/h3\u003e\n\u003cul class=\"brand-list\"\u003e\n\u003cli\u003eClinicians expecting an autonomous diagnosis, since every result must be reviewed by an accredited doctor\u003c\/li\u003e\n\u003cli\u003eLaboratories that have not digitised their slides, as whole-slide images are the only accepted input\u003c\/li\u003e\n\u003cli\u003eTeams working on organs other than breast and skin, which the current range does not cover\u003c\/li\u003e\n\u003cli\u003eBuyers who need a published price list or self-service sign-up, as everything goes through a sales demo\u003c\/li\u003e\n\u003cli\u003eAnyone relying on micrometastasis detection, which the vendor places explicitly outside its CE marking\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\n\u003csection class=\"block soft\" id=\"how\"\u003e\u003cdiv class=\"head\"\u003e\n\u003cspan class=\"eyebrow\"\u003eGet started\u003c\/span\u003e\u003ch2\u003eHow to use Primaa\u003c\/h2\u003e\n\u003cp class=\"lead\"\u003eA typical end-to-end flow, from setup to results.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003col class=\"steps\"\u003e\n\u003cli\u003eConfirm your laboratory digitises slides, since whole-slide images are the only input the platform accepts\u003c\/li\u003e\n\u003cli\u003eRequest a demonstration through the form on the Primaa website, the single commercial entry point\u003c\/li\u003e\n\u003cli\u003eScope with Primaa which solution applies: Cleo Breast for breast tissue, Cleo Skin for dermatopathology\u003c\/li\u003e\n\u003cli\u003eAgree the deployment so that data stays within your own network, as the vendor describes\u003c\/li\u003e\n\u003cli\u003eConnect the solution to your existing laboratory workflow and laboratory machines\u003c\/li\u003e\n\u003cli\u003eAccess it through your digital pathology platform if you already run PathPresenter, Proscia, PathAI or Gestalt PathFlow\u003c\/li\u003e\n\u003cli\u003eLet the algorithm perform the first read and populate the smart work list\u003c\/li\u003e\n\u003cli\u003eWork through the prioritised case list, starting with the cases flagged as most critical\u003c\/li\u003e\n\u003cli\u003eReview the heatmaps, mitosis counts, measurements and margins produced for each slide\u003c\/li\u003e\n\u003cli\u003eValidate every result yourself, as the output is an aid to diagnosis requiring accredited medical review\u003c\/li\u003e\n\u003c\/ol\u003e\u003c\/section\u003e\n\u003csection class=\"block\" id=\"proscons\"\u003e\u003cdiv class=\"head\"\u003e\n\u003cspan class=\"eyebrow\"\u003eQuick read\u003c\/span\u003e\u003ch2\u003ePros \u0026amp; Cons\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"grid-2\"\u003e\n\u003cdiv class=\"pc pros\"\u003e\n\u003ch3\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003ccircle cx=\"12\" cy=\"12\" r=\"10\"\u003e\u003c\/circle\u003e\u003cpath d=\"m9 12 2 2 4-4\"\u003e\u003c\/path\u003e\u003c\/svg\u003e Pros\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpolyline points=\"20 6 9 17 4 12\"\u003e\u003c\/polyline\u003e\u003c\/svg\u003e \u003cspan\u003eTwo CE-IVDR marked solutions, Cleo Skin being presented as a world first in dermatopathology\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpolyline points=\"20 6 9 17 4 12\"\u003e\u003c\/polyline\u003e\u003c\/svg\u003e \u003cspan\u003ePeer-reviewed evidence, including a PLOS Digital Health publication and further papers in 2024 and 2025\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpolyline points=\"20 6 9 17 4 12\"\u003e\u003c\/polyline\u003e\u003c\/svg\u003e \u003cspan\u003ePublished reading-time savings of 14% for invasive and in situ carcinoma, 50% for mitoses and 32% for macrometastases\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpolyline points=\"20 6 9 17 4 12\"\u003e\u003c\/polyline\u003e\u003c\/svg\u003e \u003cspan\u003eData stays within the customer's own network, with no personal data collection claimed\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpolyline points=\"20 6 9 17 4 12\"\u003e\u003c\/polyline\u003e\u003c\/svg\u003e \u003cspan\u003eDocumented integrations with four established digital pathology platforms\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpolyline points=\"20 6 9 17 4 12\"\u003e\u003c\/polyline\u003e\u003c\/svg\u003e \u003cspan\u003eReal clinical adoption at named institutions including AP-HP, Institut Curie, CHU Rennes and CHU Grenoble Alpes\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpolyline points=\"20 6 9 17 4 12\"\u003e\u003c\/polyline\u003e\u003c\/svg\u003e \u003cspan\u003eNamed, attributable testimonials from hospital pathologists rather than anonymous quotes\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pc cons\"\u003e\n\u003ch3\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"16\" height=\"16\"\u003e\u003ccircle cx=\"12\" cy=\"12\" r=\"10\"\u003e\u003c\/circle\u003e\u003cline x1=\"4.93\" y1=\"4.93\" x2=\"19.07\" y2=\"19.07\"\u003e\u003c\/line\u003e\u003c\/svg\u003e Cons\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cline x1=\"18\" y1=\"6\" x2=\"6\" y2=\"18\"\u003e\u003c\/line\u003e\u003cline x1=\"6\" y1=\"6\" x2=\"18\" y2=\"18\"\u003e\u003c\/line\u003e\u003c\/svg\u003e \u003cspan\u003eNo public pricing whatsoever: no rate card, no plan and no free trial, so every purchase runs through sales\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cline x1=\"18\" y1=\"6\" x2=\"6\" y2=\"18\"\u003e\u003c\/line\u003e\u003cline x1=\"6\" y1=\"6\" x2=\"18\" y2=\"18\"\u003e\u003c\/line\u003e\u003c\/svg\u003e \u003cspan\u003eCoverage limited to two organs, breast and skin, with the multi-organ roadmap still announced rather than shipped\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cline x1=\"18\" y1=\"6\" x2=\"6\" y2=\"18\"\u003e\u003c\/line\u003e\u003cline x1=\"6\" y1=\"6\" x2=\"18\" y2=\"18\"\u003e\u003c\/line\u003e\u003c\/svg\u003e \u003cspan\u003eMicrometastasis detection sits explicitly outside the CE marking, unlike macrometastases\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cline x1=\"18\" y1=\"6\" x2=\"6\" y2=\"18\"\u003e\u003c\/line\u003e\u003cline x1=\"6\" y1=\"6\" x2=\"18\" y2=\"18\"\u003e\u003c\/line\u003e\u003c\/svg\u003e \u003cspan\u003eThe privacy page exists but contains no policy text at all, leaving GDPR detail confined to the terms\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cline x1=\"18\" y1=\"6\" x2=\"6\" y2=\"18\"\u003e\u003c\/line\u003e\u003cline x1=\"6\" y1=\"6\" x2=\"18\" y2=\"18\"\u003e\u003c\/line\u003e\u003c\/svg\u003e \u003cspan\u003eNo data processing agreement, no subprocessor list and no published stance on model training\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cline x1=\"18\" y1=\"6\" x2=\"6\" y2=\"18\"\u003e\u003c\/line\u003e\u003cline x1=\"6\" y1=\"6\" x2=\"18\" y2=\"18\"\u003e\u003c\/line\u003e\u003c\/svg\u003e \u003cspan\u003eA blanket 'Research Use Only' footer sits awkwardly beside the CE-IVDR claims made on the product pages\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cline x1=\"18\" y1=\"6\" x2=\"6\" y2=\"18\"\u003e\u003c\/line\u003e\u003cline x1=\"6\" y1=\"6\" x2=\"18\" y2=\"18\"\u003e\u003c\/line\u003e\u003c\/svg\u003e \u003cspan\u003eThe footer address in Paris differs from the registered office recorded at the companies registry in Orsay\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\n\u003csection class=\"block soft\" id=\"pricing\"\u003e\u003cdiv class=\"head\"\u003e\n\u003cspan class=\"eyebrow\"\u003ePricing\u003c\/span\u003e\u003ch2\u003ePricing \u0026amp; Plans\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cp class=\"rich justify\" style=\"color:var(--gv3-ink-2);margin:0 0 18px;max-width:80ch\"\u003ePrimaa publishes no pricing of any kind. There is no pricing page, no plan, no rate card and no figure anywhere on the site, and neither a free plan nor a free trial is mentioned. The product is sold under contract, the single commercial entry point being the 'Request a demo' form, which makes this a contact-sales model. Prospective buyers should expect a quotation scoped to their laboratory rather than a published subscription price.\u003c\/p\u003e\n\u003cdiv class=\"pricing-extras\"\u003e\u003cdiv class=\"affiliate-note\"\u003ePrices and plans listed above may evolve. Always check the official pricing page before subscribing.\u003c\/div\u003e\u003c\/div\u003e\u003c\/section\u003e\n\u003csection class=\"block\" id=\"trust\"\u003e\u003cdiv class=\"head\"\u003e\n\u003cspan class=\"eyebrow\"\u003eTrust \u0026amp; Privacy\u003c\/span\u003e\u003ch2\u003eData, GDPR \u0026amp; hosting\u003c\/h2\u003e\n\u003cp class=\"lead\"\u003eA consolidated view of how Primaa handles your data.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"trust-grid\"\u003e\n\u003cdiv class=\"col\"\u003e\n\u003cdiv class=\"trust-card\"\u003e\n\u003ch3\u003eGDPR overview\u003c\/h3\u003e\n\u003cp class=\"justify\" style=\"color:var(--gv3-ink-2);margin:0\"\u003eGDPR is addressed explicitly but briefly, and entirely inside the terms and conditions rather than in a dedicated policy. Primaa states that personal information is collected and processed in compliance with Regulation 2016\/679, and cites the French Data Protection Act of 6 January 1978. A Data Protection Officer is named: co-founder Stéphane Sockeel. Access, rectification, erasure and objection rights are exercised by writing to contact@primaalab.com, and marketing data is kept for three years. On the product side, the vendor states that Cleo collects no personal data and that all data stay within the customer's network. Notably absent are any data processing agreement, subprocessor list or transfer clause, and the \/confidentialite\/ page carries no policy text.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"trust-card\"\u003e\n\u003ch3\u003eWho owns the data?\u003c\/h3\u003e\n\u003cp class=\"justify\" style=\"color:var(--gv3-ink-2);margin:0 0 12px\"\u003ePrimaa's published terms govern the primaalab.com website only, not the software itself, so no contractual clause states who owns the slide data processed by Cleo. What the product pages do say is that Cleo collects no personal data and that all data stay within the customer's own network, which leaves custody of clinical material with the laboratory. For website data, Primaa acts as the controller: it gathers non-personal browsing data plus personal data supplied through the contact, demo and newsletter forms, and grants the French statutory rights of access, rectification, erasure and objection on request by email.\u003c\/p\u003e\n\u003ch3\u003eReuse rights\u003c\/h3\u003e\n\u003cp class=\"justify\" style=\"color:var(--gv3-ink-2);margin:0\"\u003eThe terms grant the end user no reuse rights over Primaa's own material. Trademarks, logos, signs and all site content are protected by the French Intellectual Property Code, the Primaa brand is a registered trademark, and any reproduction, publication or copy requires prior authorisation. Use is limited to a strictly private context, and any commercial or advertising exploitation is expressly forbidden; anyone republishing protected content must cite the author and the source. In the opposite direction, the vendor states that Cleo collects no personal data and that all data remain inside the customer's network, so laboratory data is not presented as something Primaa reuses. No data processing agreement sets out these boundaries contractually.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"trust-card\"\u003e\n\u003ch3\u003eData retention \u0026amp; training\u003c\/h3\u003e\n\u003cdiv class=\"kv\"\u003e\n\u003cdiv class=\"k\"\u003eRetention summary\u003c\/div\u003e\n\u003cdiv class=\"v justify\"\u003eRetention is documented only for the website, not for the diagnostic platform. Personal data provided for commercial or marketing purposes is kept for three years from the date of collection or from your last contact with the company. Cookies are described as expiring at the end of the user session. Users may request access, rectification, erasure or objection at any time by emailing contact@primaalab.com. No retention period is published for data processed by Cleo itself, which is consistent with the vendor's position that the software collects no personal data and that all data remain within the customer's own network — in that model, retention is governed by the laboratory rather than by Primaa.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"kv\"\u003e\n\u003cdiv class=\"k\"\u003eGDPR contact\u003c\/div\u003e\n\u003cdiv class=\"v\"\u003e\u003ca href=\"mailto:contact@primaalab.com\"\u003econtact@primaalab.com\u003c\/a\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col\"\u003e\u003cdiv class=\"trust-card\"\u003e\n\u003ch3\u003eHosting summary\u003c\/h3\u003e\n\u003cp class=\"justify\" style=\"color:var(--gv3-ink-2);margin:0 0 14px\"\u003ePrimaa declares no hosting country and no hosting region for the platform. What it does state, on both product pages, is that Cleo collects no personal data and that all data stay within the customer's own network — a deployment posture in which clinical material never leaves the laboratory's infrastructure, so there is no vendor-side jurisdiction to declare. That claim is the vendor's own and is not backed on the site by a hosting annex, a data processing agreement or a subprocessor list. One distinction is worth keeping clear: the primaalab.com marketing site is served from French infrastructure, but that concerns the website only and says nothing about where the diagnostic platform runs. The company itself is established in France and applies French law, so any processing it does perform on its own account falls under French and EU jurisdiction. Laboratories with formal hosting requirements, including health-data hosting obligations, will need to obtain those commitments contractually.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\n\u003csection class=\"block watch\" id=\"watch\"\u003e\u003cdiv class=\"head\"\u003e\n\u003cspan class=\"eyebrow\"\u003eWatch-outs\u003c\/span\u003e\u003ch2\u003eThings to keep in mind\u003c\/h2\u003e\n\u003cp class=\"lead\"\u003eRisks and trade-offs to weigh before adopting Primaa.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cul class=\"brand-list\" style=\"grid-template-columns:repeat(2,1fr);display:grid;gap:12px 24px\"\u003e\n\u003cli\u003eAutomation bias is the central clinical risk: a confident heatmap can anchor a pathologist's judgement, and the vendor's own instruction that results must be reviewed by accredited doctors only works if that review stays genuinely independent\u003c\/li\u003e\n\u003cli\u003eDeskilling over time, particularly for trainees who may learn to confirm the algorithm's mitosis counts and margins rather than to establish them unaided\u003c\/li\u003e\n\u003cli\u003eThe smart work list reorders clinical priorities, so a case wrongly ranked as low-risk may simply wait longer before a human ever looks at it\u003c\/li\u003e\n\u003cli\u003eMicrometastases fall outside the CE marking while macrometastases do not, a distinction easy to lose in daily use and consequential for staging\u003c\/li\u003e\n\u003cli\u003eThe absence of any data processing agreement, subprocessor list or published training policy leaves patient-data governance to be negotiated privately rather than verified publicly\u003c\/li\u003e\n\u003cli\u003eThe 'Research Use Only' footer contradicts the CE-IVDR claims on the product pages, and using the wrong reading of that notice has regulatory consequences either way\u003c\/li\u003e\n\u003cli\u003ePublished time savings were measured in specific studies and settings, and should not be assumed to transfer unchanged to a different laboratory, scanner or case mix\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/section\u003e\n\u003csection class=\"block\" id=\"setup\"\u003e\u003cdiv class=\"head\"\u003e\n\u003cspan class=\"eyebrow\"\u003eSetup\u003c\/span\u003e\u003ch2\u003eSetup \u0026amp; Integrations\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"setup-grid\"\u003e\n\u003cdiv class=\"setup-card\"\u003e\n\u003ch3 style=\"font-size:15px;margin-bottom:10px\"\u003eTechnical difficulty\u003c\/h3\u003e\n\u003cp class=\"justify\" style=\"color:var(--gv3-ink-2);margin:0 0 14px\"\u003eNon-trivial, and institutional rather than individual. There is no self-service sign-up: deployment is scoped through a sales demonstration, then installed into the laboratory environment and connected to existing laboratory machines. Slide digitisation is a hard prerequisite. The effort is lighter for laboratories already running PathPresenter, Proscia, PathAI or Gestalt PathFlow, where Cleo reaches users through a platform already in place. Primaa describes the solution as vendor-agnostic and interoperable, but publishes no technical documentation and no API, so integration planning depends entirely on direct vendor support.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"setup-card\"\u003e\n\u003ch3 style=\"font-size:15px;margin-bottom:10px\"\u003eIntegrations\u003c\/h3\u003e\n\u003cdiv class=\"integrations\"\u003e\n\u003cspan class=\"integration\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpath d=\"M6.3 20.3a2.4 2.4 0 0 0 3.4 0L12 18l-6-6-2.3 2.3a2.4 2.4 0 0 0 0 3.4Z\"\u003e\u003c\/path\u003e\u003cpath d=\"m2 22 3-3\"\u003e\u003c\/path\u003e\u003cpath d=\"M7.5 13.5 10 11\"\u003e\u003c\/path\u003e\u003cpath d=\"M10.5 16.5 13 14\"\u003e\u003c\/path\u003e\u003cpath d=\"m18 3-4 4h6l-4 4\"\u003e\u003c\/path\u003e\u003c\/svg\u003e PathPresenter\u003c\/span\u003e\u003cspan class=\"integration\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpath d=\"M6.3 20.3a2.4 2.4 0 0 0 3.4 0L12 18l-6-6-2.3 2.3a2.4 2.4 0 0 0 0 3.4Z\"\u003e\u003c\/path\u003e\u003cpath d=\"m2 22 3-3\"\u003e\u003c\/path\u003e\u003cpath d=\"M7.5 13.5 10 11\"\u003e\u003c\/path\u003e\u003cpath d=\"M10.5 16.5 13 14\"\u003e\u003c\/path\u003e\u003cpath d=\"m18 3-4 4h6l-4 4\"\u003e\u003c\/path\u003e\u003c\/svg\u003e Proscia\u003c\/span\u003e\u003cspan class=\"integration\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpath d=\"M6.3 20.3a2.4 2.4 0 0 0 3.4 0L12 18l-6-6-2.3 2.3a2.4 2.4 0 0 0 0 3.4Z\"\u003e\u003c\/path\u003e\u003cpath d=\"m2 22 3-3\"\u003e\u003c\/path\u003e\u003cpath d=\"M7.5 13.5 10 11\"\u003e\u003c\/path\u003e\u003cpath d=\"M10.5 16.5 13 14\"\u003e\u003c\/path\u003e\u003cpath d=\"m18 3-4 4h6l-4 4\"\u003e\u003c\/path\u003e\u003c\/svg\u003e PathAI\u003c\/span\u003e\u003cspan class=\"integration\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpath d=\"M6.3 20.3a2.4 2.4 0 0 0 3.4 0L12 18l-6-6-2.3 2.3a2.4 2.4 0 0 0 0 3.4Z\"\u003e\u003c\/path\u003e\u003cpath d=\"m2 22 3-3\"\u003e\u003c\/path\u003e\u003cpath d=\"M7.5 13.5 10 11\"\u003e\u003c\/path\u003e\u003cpath d=\"M10.5 16.5 13 14\"\u003e\u003c\/path\u003e\u003cpath d=\"m18 3-4 4h6l-4 4\"\u003e\u003c\/path\u003e\u003c\/svg\u003e Gestalt\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\n\u003csection class=\"block soft\" id=\"company\"\u003e\u003cdiv class=\"head\"\u003e\n\u003cspan class=\"eyebrow\"\u003eCompany\u003c\/span\u003e\u003ch2\u003eBehind Primaa\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"company-grid\"\u003e\n\u003cdiv class=\"company-card\"\u003e\n\u003cdiv class=\"kv\"\u003e\n\u003cdiv class=\"k\"\u003eCompany name\u003c\/div\u003e\n\u003cdiv class=\"v\"\u003e\u003cb\u003ePrimaa SAS\u003c\/b\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"kv\"\u003e\n\u003cdiv class=\"k\"\u003eFounded\u003c\/div\u003e\n\u003cdiv class=\"v\"\u003e25\/09\/2018\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"kv\"\u003e\n\u003cdiv class=\"k\"\u003eCountry of origin\u003c\/div\u003e\n\u003cdiv class=\"v\"\u003e🇫🇷 France\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"kv\"\u003e\n\u003cdiv class=\"k\"\u003eHeadquarters\u003c\/div\u003e\n\u003cdiv class=\"v\"\u003e6, Bd Dubreuil, 91400 Orsay, France\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"kv\"\u003e\n\u003cdiv class=\"k\"\u003eUBO\u003c\/div\u003e\n\u003cdiv class=\"v\"\u003eINFORMATION_NOT_FOUND\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"kv\"\u003e\n\u003cdiv class=\"k\"\u003eUBO country\u003c\/div\u003e\n\u003cdiv class=\"v\"\u003eINFORMATION_NOT_FOUND\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"kv\"\u003e\n\u003cdiv class=\"k\"\u003eDomain registrar country\u003c\/div\u003e\n\u003cdiv class=\"v\"\u003e🇫🇷 France\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"display:grid;gap:14px\"\u003e\n\u003cdiv class=\"company-card\"\u003e\n\u003ch3 style=\"font-size:15px;margin-bottom:10px\"\u003eFundraising\u003c\/h3\u003e\n\u003cdiv class=\"timeline\"\u003e\n\u003cdiv class=\"ev\"\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpath d=\"M4.5 16.5c-1.5 1.26-2 5-2 5s3.74-.5 5-2c.71-.84.7-2.13-.09-2.91a2.18 2.18 0 0 0-2.91-.09z\"\u003e\u003c\/path\u003e\u003cpath d=\"m12 15-3-3a22 22 0 0 1 2-3.95A12.88 12.88 0 0 1 22 2c0 2.72-.78 7.5-6 11a22.35 22.35 0 0 1-4 2z\"\u003e\u003c\/path\u003e\u003cpath d=\"M9 12H4s.55-3.03 2-4c1.62-1.08 5 0 5 0\"\u003e\u003c\/path\u003e\u003cpath d=\"M12 15v5s3.03-.55 4-2c1.08-1.62 0-5 0-5\"\u003e\u003c\/path\u003e\u003c\/svg\u003e Pre-seed round in 2019, the company's first equity round, with 50 Partners named as its first backer\u003c\/div\u003e\n\u003cdiv class=\"ev\"\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpath d=\"M4.5 16.5c-1.5 1.26-2 5-2 5s3.74-.5 5-2c.71-.84.7-2.13-.09-2.91a2.18 2.18 0 0 0-2.91-.09z\"\u003e\u003c\/path\u003e\u003cpath d=\"m12 15-3-3a22 22 0 0 1 2-3.95A12.88 12.88 0 0 1 22 2c0 2.72-.78 7.5-6 11a22.35 22.35 0 0 1-4 2z\"\u003e\u003c\/path\u003e\u003cpath d=\"M9 12H4s.55-3.03 2-4c1.62-1.08 5 0 5 0\"\u003e\u003c\/path\u003e\u003cpath d=\"M12 15v5s3.03-.55 4-2c1.08-1.62 0-5 0-5\"\u003e\u003c\/path\u003e\u003c\/svg\u003e Pre-Series A round closed in 2024 to finance international expansion and accelerate the multi-organ AI roadmap\u003c\/div\u003e\n\u003cdiv class=\"ev\"\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpath d=\"M4.5 16.5c-1.5 1.26-2 5-2 5s3.74-.5 5-2c.71-.84.7-2.13-.09-2.91a2.18 2.18 0 0 0-2.91-.09z\"\u003e\u003c\/path\u003e\u003cpath d=\"m12 15-3-3a22 22 0 0 1 2-3.95A12.88 12.88 0 0 1 22 2c0 2.72-.78 7.5-6 11a22.35 22.35 0 0 1-4 2z\"\u003e\u003c\/path\u003e\u003cpath d=\"M9 12H4s.55-3.03 2-4c1.62-1.08 5 0 5 0\"\u003e\u003c\/path\u003e\u003cpath d=\"M12 15v5s3.03-.55 4-2c1.08-1.62 0-5 0-5\"\u003e\u003c\/path\u003e\u003c\/svg\u003e No amount is disclosed for either round\u003c\/div\u003e\n\u003cdiv class=\"ev\"\u003e\n\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpath d=\"M4.5 16.5c-1.5 1.26-2 5-2 5s3.74-.5 5-2c.71-.84.7-2.13-.09-2.91a2.18 2.18 0 0 0-2.91-.09z\"\u003e\u003c\/path\u003e\u003cpath d=\"m12 15-3-3a22 22 0 0 1 2-3.95A12.88 12.88 0 0 1 22 2c0 2.72-.78 7.5-6 11a22.35 22.35 0 0 1-4 2z\"\u003e\u003c\/path\u003e\u003cpath d=\"M9 12H4s.55-3.03 2-4c1.62-1.08 5 0 5 0\"\u003e\u003c\/path\u003e\u003cpath d=\"M12 15v5s3.03-.55 4-2c1.08-1.62 0-5 0-5\"\u003e\u003c\/path\u003e\u003c\/svg\u003e Investors presented by the company: Matmut, Pléiade Investissement, Bpifrance, 50 Partners, SWEN Capital Partners and Elaia\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"company-card\"\u003e\n\u003ch3 style=\"font-size:15px;margin-bottom:10px\"\u003eSocial\u003c\/h3\u003e\n\u003cdiv class=\"social-row\"\u003e\u003ca class=\"social\" href=\"https:\/\/fr.linkedin.com\/company\/primaa\" target=\"_blank\" rel=\"noopener\" aria-label=\"LinkedIn\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"18\" height=\"18\"\u003e\u003cpath d=\"M16 8a6 6 0 0 1 6 6v7h-4v-7a2 2 0 0 0-4 0v7h-4v-7a6 6 0 0 1 6-6z\"\u003e\u003c\/path\u003e\u003crect x=\"2\" y=\"9\" width=\"4\" height=\"12\"\u003e\u003c\/rect\u003e\u003ccircle cx=\"4\" cy=\"4\" r=\"2\"\u003e\u003c\/circle\u003e\u003c\/svg\u003e\u003c\/a\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\n\u003csection class=\"block\" id=\"resources\"\u003e\u003cdiv class=\"head\"\u003e\n\u003cspan class=\"eyebrow\"\u003eOfficial links\u003c\/span\u003e\u003ch2\u003eResources\u003c\/h2\u003e\n\u003cp class=\"lead\"\u003eAll the official URLs gathered for verification and reference.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"res-grid\"\u003e\n\u003ca class=\"res\" href=\"https:\/\/primaalab.com\/\" target=\"_blank\" rel=\"noopener\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003ccircle cx=\"12\" cy=\"12\" r=\"10\"\u003e\u003c\/circle\u003e\u003cpath d=\"M12 2a14.5 14.5 0 0 0 0 20 14.5 14.5 0 0 0 0-20\"\u003e\u003c\/path\u003e\u003cpath d=\"M2 12h20\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003cdiv class=\"res-text\"\u003e\n\u003cdiv\u003eHomepage\u003c\/div\u003e\n\u003cdiv class=\"url\"\u003eprimaalab.com\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/a\u003e\u003ca class=\"res\" href=\"https:\/\/primaalab.com\/solutions\/\" target=\"_blank\" rel=\"noopener\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpolygon points=\"12 2 2 7 12 12 22 7 12 2\"\u003e\u003c\/polygon\u003e\u003cpolyline points=\"2 17 12 22 22 17\"\u003e\u003c\/polyline\u003e\u003cpolyline points=\"2 12 12 17 22 12\"\u003e\u003c\/polyline\u003e\u003c\/svg\u003e\u003cdiv class=\"res-text\"\u003e\n\u003cdiv\u003eFeatures\u003c\/div\u003e\n\u003cdiv class=\"url\"\u003eprimaalab.com\/solutions\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/a\u003e\u003ca class=\"res\" href=\"https:\/\/primaalab.com\/about\/\" target=\"_blank\" rel=\"noopener\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003ccircle cx=\"12\" cy=\"12\" r=\"10\"\u003e\u003c\/circle\u003e\u003cline x1=\"12\" y1=\"16\" x2=\"12\" y2=\"12\"\u003e\u003c\/line\u003e\u003cline x1=\"12\" y1=\"8\" x2=\"12.01\" y2=\"8\"\u003e\u003c\/line\u003e\u003c\/svg\u003e\u003cdiv class=\"res-text\"\u003e\n\u003cdiv\u003eAbout\u003c\/div\u003e\n\u003cdiv class=\"url\"\u003eprimaalab.com\/about\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/a\u003e\u003ca class=\"res\" href=\"https:\/\/primaalab.com\/terms-and-conditions\/\" target=\"_blank\" rel=\"noopener\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpath d=\"M14 2H6a2 2 0 0 0-2 2v16a2 2 0 0 0 2 2h12a2 2 0 0 0 2-2V8z\"\u003e\u003c\/path\u003e\u003cpolyline points=\"14 2 14 8 20 8\"\u003e\u003c\/polyline\u003e\u003cline x1=\"16\" y1=\"13\" x2=\"8\" y2=\"13\"\u003e\u003c\/line\u003e\u003cline x1=\"16\" y1=\"17\" x2=\"8\" y2=\"17\"\u003e\u003c\/line\u003e\u003cpolyline points=\"10 9 9 9 8 9\"\u003e\u003c\/polyline\u003e\u003c\/svg\u003e\u003cdiv class=\"res-text\"\u003e\n\u003cdiv\u003eTerms\u003c\/div\u003e\n\u003cdiv class=\"url\"\u003eprimaalab.com\/terms-and-conditions\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/a\u003e\u003ca class=\"res\" href=\"https:\/\/primaalab.com\/confidentialite\/\" target=\"_blank\" rel=\"noopener\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cpath d=\"M12 22s8-4 8-10V5l-8-3-8 3v7c0 6 8 10 8 10z\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003cdiv class=\"res-text\"\u003e\n\u003cdiv\u003ePrivacy policy\u003c\/div\u003e\n\u003cdiv class=\"url\"\u003eprimaalab.com\/confidentialite\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/a\u003e\n\u003c\/div\u003e\u003c\/section\u003e\n\u003csection class=\"block\" id=\"faq\"\u003e\u003cdiv class=\"head\"\u003e\n\u003cspan class=\"eyebrow\"\u003eFAQ\u003c\/span\u003e\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"faq\"\u003e\n\u003cdetails\u003e\u003csummary\u003eWhat does Primaa actually do? \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cline x1=\"12\" y1=\"5\" x2=\"12\" y2=\"19\"\u003e\u003c\/line\u003e\u003cline x1=\"5\" y1=\"12\" x2=\"19\" y2=\"12\"\u003e\u003c\/line\u003e\u003c\/svg\u003e\u003c\/summary\u003e\u003cdiv class=\"ans justify\"\u003ePrimaa develops an AI platform that reads digitised histology slides to help pathologists detect and quantify cancer biomarkers, combining image analysis with deep learning.\u003c\/div\u003e\u003c\/details\u003e\u003cdetails\u003e\u003csummary\u003eWhich solutions does the Cleo range include? \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cline x1=\"12\" y1=\"5\" x2=\"12\" y2=\"19\"\u003e\u003c\/line\u003e\u003cline x1=\"5\" y1=\"12\" x2=\"19\" y2=\"12\"\u003e\u003c\/line\u003e\u003c\/svg\u003e\u003c\/summary\u003e\u003cdiv class=\"ans justify\"\u003eTwo: Cleo Breast for breast tissue and Cleo Skin for dermatopathology. Both carry CE-IVDR marking, and Cleo Skin is presented as the world's first CE-IVDR marked AI solution for dermatopathology.\u003c\/div\u003e\u003c\/details\u003e\u003cdetails\u003e\u003csummary\u003eWhich biomarkers does Cleo Breast detect? \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cline x1=\"12\" y1=\"5\" x2=\"12\" y2=\"19\"\u003e\u003c\/line\u003e\u003cline x1=\"5\" y1=\"12\" x2=\"19\" y2=\"12\"\u003e\u003c\/line\u003e\u003c\/svg\u003e\u003c\/summary\u003e\u003cdiv class=\"ans justify\"\u003eInvasive and in situ carcinoma, mitoses, calcifications and metastases on lymph node slides. Macrometastases are CE marked; micrometastases explicitly are not.\u003c\/div\u003e\u003c\/details\u003e\u003cdetails\u003e\u003csummary\u003eWhich lesions does Cleo Skin cover? \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cline x1=\"12\" y1=\"5\" x2=\"12\" y2=\"19\"\u003e\u003c\/line\u003e\u003cline x1=\"5\" y1=\"12\" x2=\"19\" y2=\"12\"\u003e\u003c\/line\u003e\u003c\/svg\u003e\u003c\/summary\u003e\u003cdiv class=\"ans justify\"\u003eMelanoma, naevus, squamous cell carcinoma and basal cell carcinoma, together with automatic measurement of lesion dimensions and margins and detection of mitoses in melanoma regions.\u003c\/div\u003e\u003c\/details\u003e\u003cdetails\u003e\u003csummary\u003eDoes it replace the pathologist? \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cline x1=\"12\" y1=\"5\" x2=\"12\" y2=\"19\"\u003e\u003c\/line\u003e\u003cline x1=\"5\" y1=\"12\" x2=\"19\" y2=\"12\"\u003e\u003c\/line\u003e\u003c\/svg\u003e\u003c\/summary\u003e\u003cdiv class=\"ans justify\"\u003eNo. Primaa describes Cleo as an aid to diagnosis whose results must be reviewed by accredited doctors. It performs a first read and prioritises cases; the clinical decision remains medical.\u003c\/div\u003e\u003c\/details\u003e\u003cdetails\u003e\u003csummary\u003eWhere does my data go? \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cline x1=\"12\" y1=\"5\" x2=\"12\" y2=\"19\"\u003e\u003c\/line\u003e\u003cline x1=\"5\" y1=\"12\" x2=\"19\" y2=\"12\"\u003e\u003c\/line\u003e\u003c\/svg\u003e\u003c\/summary\u003e\u003cdiv class=\"ans justify\"\u003eAccording to Primaa, Cleo collects no personal data and all data stay within your own network. No hosting country or region is declared for the platform itself.\u003c\/div\u003e\u003c\/details\u003e\u003cdetails\u003e\u003csummary\u003eHow much does it cost? \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cline x1=\"12\" y1=\"5\" x2=\"12\" y2=\"19\"\u003e\u003c\/line\u003e\u003cline x1=\"5\" y1=\"12\" x2=\"19\" y2=\"12\"\u003e\u003c\/line\u003e\u003c\/svg\u003e\u003c\/summary\u003e\u003cdiv class=\"ans justify\"\u003eNo price is published anywhere on the site. There is no pricing page, no plan and no free trial; the product is sold under contract and access starts with a demonstration request.\u003c\/div\u003e\u003c\/details\u003e\u003cdetails\u003e\u003csummary\u003eIs there an API? \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cline x1=\"12\" y1=\"5\" x2=\"12\" y2=\"19\"\u003e\u003c\/line\u003e\u003cline x1=\"5\" y1=\"12\" x2=\"19\" y2=\"12\"\u003e\u003c\/line\u003e\u003c\/svg\u003e\u003c\/summary\u003e\u003cdiv class=\"ans justify\"\u003eNo API documentation is published. Every documentation path tested returns the site's standard not-found page, so no public API offering is discoverable.\u003c\/div\u003e\u003c\/details\u003e\u003cdetails\u003e\u003csummary\u003eWhich platforms does it integrate with? \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cline x1=\"12\" y1=\"5\" x2=\"12\" y2=\"19\"\u003e\u003c\/line\u003e\u003cline x1=\"5\" y1=\"12\" x2=\"19\" y2=\"12\"\u003e\u003c\/line\u003e\u003c\/svg\u003e\u003c\/summary\u003e\u003cdiv class=\"ans justify\"\u003ePrimaa names PathPresenter, Proscia, PathAI and Gestalt PathFlow as platforms into which Cleo is integrated, and describes the solution as vendor-agnostic and interoperable.\u003c\/div\u003e\u003c\/details\u003e\u003cdetails\u003e\u003csummary\u003eWhat scientific evidence supports it? \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"14\" height=\"14\"\u003e\u003cline x1=\"12\" y1=\"5\" x2=\"12\" y2=\"19\"\u003e\u003c\/line\u003e\u003cline x1=\"5\" y1=\"12\" x2=\"19\" y2=\"12\"\u003e\u003c\/line\u003e\u003c\/svg\u003e\u003c\/summary\u003e\u003cdiv class=\"ans justify\"\u003ePublications in PLOS Digital Health on multi-centre invasive carcinoma detection, work on stain adaptation and on AI-based mitosis detection, plus a study measuring reading-time savings with Cleo Breast.\u003c\/div\u003e\u003c\/details\u003e\n\u003c\/div\u003e\u003c\/section\u003e\n\u003csection class=\"block conclusion\" id=\"conclusion\"\u003e\u003cdiv class=\"head\"\u003e\n\u003cspan class=\"eyebrow\"\u003eConclusion\u003c\/span\u003e\u003ch2\u003eShould you pick Primaa?\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"rich justify\" style=\"max-width:80ch\"\u003e\n\u003cp\u003ePrimaa occupies a narrow, serious niche. This is not a general-purpose AI product but a regulated \u003ci\u003ein vitro\u003c\/i\u003e diagnostic device aimed at pathologists working on digitised slides, and it should be judged on medical-device criteria rather than software ones. On those criteria it holds up well: both Cleo Breast and Cleo Skin carry CE-IVDR marking, the evidence base is peer-reviewed rather than promotional, reading-time savings are quantified and published, and adoption at named institutions such as AP-HP, Institut Curie and several French university hospitals is documented rather than merely claimed. The data posture is unusually favourable too: the vendor states that no personal data is collected and that everything stays inside the laboratory's own network.\u003c\/p\u003e\n\u003cp\u003eThe reservations are mostly documentary and commercial. Pricing is entirely opaque, with no rate card, no plan and no trial, so evaluation necessarily begins with a sales conversation. The product-side legal documentation is thin: the privacy page is empty, there is no data processing agreement, no subprocessor list and no published position on model training — gaps that a hospital procurement team will have to close directly with the vendor. A blanket \u003ci\u003eResearch Use Only\u003c\/i\u003e footer also sits awkwardly beside the CE-IVDR claims made on the product pages, and deserves clarification.\u003c\/p\u003e\n\u003cp\u003eScope is the other limit. Two organs are covered today, breast and skin, with a multi-organ roadmap announced but not delivered, and micrometastasis detection falls outside the CE marking. For a digital pathology laboratory already reporting breast or skin cases at volume, Primaa is a credible, evidence-backed first-read assistant. For anyone else, it is probably too early or too specialised.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"cta-row\"\u003e\u003ca class=\"btn btn-primary\" href=\"https:\/\/primaalab.com\/\" target=\"_blank\" rel=\"noopener\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\" width=\"16\" height=\"16\"\u003e\u003cpath d=\"M15 3h6v6\"\u003e\u003c\/path\u003e\u003cpath d=\"M10 14 21 3\"\u003e\u003c\/path\u003e\u003cpath d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\u003e\u003c\/path\u003e\u003c\/svg\u003e Visit Primaa\u003c\/a\u003e\u003c\/div\u003e\u003c\/section\u003e\n\u003c\/div\u003e","brand":"Primaa SAS","offers":[{"title":"Default Title","offer_id":58389747302731,"sku":null,"price":0.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1038\/0905\/7099\/files\/official-primaa-by-guidaio_55751a00-be1f-45fc-8abd-ed818562c52a.png?v=1788734400","url":"https:\/\/guidaio.com\/products\/primaa","provider":"Guidaio","version":"1.0","type":"link"}